Skip to main content
icon for 4月30日までに米国ではしかの症例がありますか?

4月30日までに米国ではしかの症例がありますか?

icon for 4月30日までに米国ではしかの症例がありますか?

4月30日までに米国ではしかの症例がありますか?

$479,297 Vol.

2026/04/30
Polymarket

$479,297 Vol.

Polymarket

1750

$21,777 Vol.

はい

1775

$39,332 Vol.

はい

1800

$168,010 Vol.

いいえ

1900

$74,279 Vol.

いいえ

1850

$27,965 Vol.

いいえ

2000

$57,355 Vol.

いいえ

1950

$36,078 Vol.

いいえ

2100

$18,603 Vol.

いいえ

2200

$35,898 Vol.

いいえ

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
音量
$479,297
終了日
2026/04/30
マーケット開始日
Apr 16, 2026, 10:34 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

提案された結果: はい

異議申し立てなし

最終結果: はい

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
音量
$479,297
終了日
2026/04/30
マーケット開始日
Apr 16, 2026, 10:34 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

提案された結果: はい

異議申し立てなし

最終結果: はい

外部リンクに注意してください。

よくある質問

「4月30日までに米国ではしかの症例がありますか?」はPolymarket上の9個の結果が可能な予測市場で、トレーダーが何が起こるかに基づいてシェアを売買します。現在のリード結果は「1750」で100%、次いで「1775」が100%です。価格はコミュニティのリアルタイム確率を反映しています。例えば、100¢で取引されているシェアは、市場がその結果に100%の確率を集合的に割り当てていることを意味します。これらのオッズは継続的に変化します。正しい結果のシェアは市場決済時に各$1で引き換え可能です。

本日現在、「4月30日までに米国ではしかの症例がありますか?」は$479.3Kの総取引量を生み出しています(Mar 24, 2026のマーケット開始以来)。この取引活動レベルはPolymarketコミュニティの強い関与を反映し、現在のオッズが幅広い市場参加者によって形成されていることを保証します。このページで直接、ライブの価格変動を追跡し、任意の結果で取引できます。

「4月30日までに米国ではしかの症例がありますか?」で取引するには、このページに記載されている9個の利用可能な結果を閲覧します。各結果には市場の暗示確率を表す現在の価格が表示されています。ポジションを取るには、最も可能性が高いと思う結果を選び、「はい」で支持するか「いいえ」で反対するかを選択し、金額を入力して「取引」をクリックします。選んだ結果が市場決済時に正しければ、「はい」のシェアは各$1を支払います。正しくなければ$0です。決済前にいつでもシェアを売却できます。

「4月30日までに米国ではしかの症例がありますか?」の現在のフロントランナーは「1750」で100%であり、市場がこの結果に100%の確率を割り当てていることを意味します。次に近い結果は「1775」で100%です。これらのオッズはトレーダーがシェアを売買するにつれてリアルタイムで更新されます。頻繁に確認するか、このページをブックマークしてください。

「4月30日までに米国ではしかの症例がありますか?」の決済ルールは、各結果が勝者と宣言されるために何が起こる必要があるかを正確に定義しています。これには結果を決定するために使用される公式データソースも含まれます。このページのコメント上にある「ルール」セクションで完全な決済基準を確認できます。取引前にルールを注意深く読むことをお勧めします。